Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,555
Total Claims
$546K
Drug Cost
591
Beneficiaries
$924
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-21%
Cost per patient vs peers
$924 vs $1,174 avg
+29%
Brand preference vs peers
11.4% vs 8.9% avg
Brand vs Generic
Brand: 970 claims · $368K
Generic: 7,536 claims · $176K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 165 | $106K |
| Linagliptin | 43 | $27K |
| Rivaroxaban | 38 | $26K |
| Linaclotide | 31 | $20K |
| Risperidone Microspheres | 14 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 26 | $13K |
| Fluticasone/Umeclidin/Vilanter | 18 | $12K |
| Semaglutide | 12 | $12K |
| Mirabegron | 26 | $11K |
| Dapagliflozin Propanediol | 17 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 22 | $9,426 |
| Fluticasone/Vilanterol | 21 | $8,927 |
| Aripiprazole | 34 | $8,011 |
| Tiotropium Bromide | 12 | $6,454 |
| Atorvastatin Calcium | 355 | $5,727 |
Prescribing Profile
Patient Profile
83
Avg Age
71%
Female
2.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data